Foghorn Therapeutics Inc. — All Filings
329 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
10-Q/A
144
3
3/A
4
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
DEF 14A
DEFA14A
DRS
EFFECT
POS AM
S-1
S-1/A
S-3
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| S-8 | S-8 | 0001628280-26-021405 | Mar 26, 2026 | — |
| 10-K | 10-K | 0001628280-26-016814 | Mar 11, 2026 | Dec 31, 2025 |
| 8-K | 8-K | 0001628280-26-016805 | Mar 11, 2026 | — |
| 4 | PRIMARY DOCUMENT | 0001363984-26-000004 | Feb 24, 2026 | Feb 23, 2026 |
| 3 | PRIMARY DOCUMENT | 0001363984-26-000003 | Feb 24, 2026 | Feb 23, 2026 |
| 8-K | 8-K | 0001628280-26-010377 | Feb 23, 2026 | — |
| 4 | PRIMARY DOCUMENT | 0001828724-26-000003 | Feb 6, 2026 | Feb 5, 2026 |
| 4 | PRIMARY DOCUMENT | 0001939167-26-000002 | Feb 2, 2026 | Jan 30, 2026 |
| 4 | PRIMARY DOCUMENT | 0001831755-26-000002 | Feb 2, 2026 | Jan 30, 2026 |
| 4 | PRIMARY DOCUMENT | 0001760104-26-000002 | Feb 2, 2026 | Jan 30, 2026 |
| 4 | PRIMARY DOCUMENT | 0002035647-26-000002 | Feb 2, 2026 | Jan 30, 2026 |
| 4 | PRIMARY DOCUMENT | 0001831749-26-000002 | Feb 2, 2026 | Jan 30, 2026 |
| 4 | 4 | 0001193125-26-014218 | Jan 15, 2026 | Jan 13, 2026 |
| SCHEDULE 13D/A | — | 0001193125-26-011881 | Jan 13, 2026 | — |
| 424B5 | 424B5 | 0001193125-26-010520 | Jan 12, 2026 | — |
| 8-K | 8-K | 0001193125-26-009885 | Jan 12, 2026 | Jan 9, 2026 |
| 8-K | 8-K | 0001628280-25-055215 | Dec 4, 2025 | Dec 3, 2025 |
| 4 | PRIMARY DOCUMENT | 0001872280-25-000003 | Nov 17, 2025 | Nov 14, 2025 |
| 8-K | 8-K | 0001628280-25-050683 | Nov 7, 2025 | — |
| 10-Q | 10-Q | 0001628280-25-049238 | Nov 5, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001628280-25-049236 | Nov 5, 2025 | — |
| 8-K | 8-K | 0001628280-25-047322 | Oct 30, 2025 | — |
| 8-K | 8-K | 0001822462-25-000007 | Sep 2, 2025 | — |
| 10-Q | 10-Q | 0001628280-25-037606 | Aug 5, 2025 | Jun 30, 2025 |
| 8-K | 8-K | 0001628280-25-037603 | Aug 5, 2025 | — |
| 8-K | 8-K | 0001628280-25-033784 | Jul 1, 2025 | Jun 27, 2025 |
| 4 | PRIMARY DOCUMENT | 0001562180-25-004909 | Jun 17, 2025 | — |
| 4 | PRIMARY DOCUMENT | 0001562180-25-004908 | Jun 17, 2025 | — |
| 4 | PRIMARY DOCUMENT | 0001562180-25-004907 | Jun 17, 2025 | — |
| 4 | PRIMARY DOCUMENT | 0001562180-25-004906 | Jun 17, 2025 | — |
| 4 | PRIMARY DOCUMENT | 0001562180-25-004902 | Jun 17, 2025 | — |
| 4 | PRIMARY DOCUMENT | 0001562180-25-004899 | Jun 17, 2025 | — |
| 4 | PRIMARY DOCUMENT | 0001562180-25-004893 | Jun 17, 2025 | — |
| 8-K | 8-K | 0001628280-25-031819 | Jun 17, 2025 | — |
| 10-Q | 10-Q | 0001628280-25-025312 | May 14, 2025 | Mar 31, 2025 |
| 8-K | 8-K | 0001628280-25-025302 | May 14, 2025 | — |
| ARS | ARS | 0001193125-25-112110 | May 5, 2025 | Dec 31, 2024 |
| DEFA14A | DEFA14A | 0001193125-25-112103 | May 5, 2025 | — |
| DEF 14A | DEF 14A | 0001193125-25-112091 | May 5, 2025 | Jun 17, 2025 |
| 4 | PRIMARY DOCUMENT | 0001562180-25-003475 | May 2, 2025 | May 1, 2025 |
| 4 | PRIMARY DOCUMENT | 0001562180-25-003474 | May 2, 2025 | May 1, 2025 |
| 3 | PRIMARY DOCUMENT | 0001562180-25-003473 | May 2, 2025 | May 1, 2025 |
| 3 | PRIMARY DOCUMENT | 0001562180-25-003472 | May 2, 2025 | May 1, 2025 |
| 8-K | 8-K | 0001628280-25-021506 | May 1, 2025 | Apr 25, 2025 |
| 8-K | 8-K | 0001628280-25-020257 | Apr 28, 2025 | — |
| 4 | PRIMARY DOCUMENT | 0001562180-25-003257 | Apr 28, 2025 | Apr 25, 2025 |
| 4 | PRIMARY DOCUMENT | 0001562180-25-003092 | Apr 10, 2025 | Apr 9, 2025 |
| 8-K | 8-K | 0001628280-25-014475 | Mar 24, 2025 | — |
| 8-K | 8-K | 0001628280-25-014136 | Mar 20, 2025 | — |
| 424B5 | 424B5 | 0001628280-25-014133 | Mar 20, 2025 | — |